Less Ads, More Data, More Tools Register for FREE

Trading Update

12 Jan 2023 07:00

RNS Number : 4516M
Xaar PLC
12 January 2023

XAAR plc聽

TRADING UPDATE

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology group, today announces a trading update for the year ended 31 December 2022.

TRADING

Strong revenue growth and full-year profitability

Revenue for the period is expected to be approximately 拢74 million (2021: 拢59.3 million), representing year on year growth of 24% driven by a combination of organic growth (9%) and acquisitions

The Group is expected to deliver an on track adjusted profit for the year

During 2022 the Group continued to invest in working capital and infrastructure development and in March completed the acquisition of Megnajet

Further operational and strategic progress

Further progress was made throughout the year in implementing the strategy to achieve long-term profitable growth

Successful launch of Aqueous printhead product in November 2022 as planned, and on budget, is receiving strong customer engagement

Factory reorganisation commenced in December and is progressing well and on schedule for completion by March 2023. This project is expected to deliver increased efficiency, reduce power usage, and reduce costs

The integration of recent acquisitions (FFEI and Megnajet) has been completed successfully and both are contributing positively to Group results聽

Continued progress at EPS delivered its best performance to date with revenue growth of 36%

Challenging macro conditions expected to continue into 2023

Sales volumes in the Printhead business continue to be affected by the uncertainty in China, which is expected to continue in the short term as Covid cases increase. At this stage it remains unclear when normal levels of business will return

We have maintained our policy of increased investment in inventory to ensure availability of product during the factory reorganisation in Q1 2023 and the remainder of the year

BALANCE SHEET AND LIQUIDITY

The Group remains well capitalised with a strong balance sheet with a net cash position as at 31 December 2022 of 拢8.6 million

John Mills, Chief Executive Officer, commented:

"I am hugely proud of the team in delivering a strong performance and making further progress with our strategy. We expect to deliver strong profitable revenue growth and the important milestone of achieving full year profitability representing great progress against our plan and remain well positioned for the business to achieve its exciting potential.

Aquinox has been successfully launched and is already being well received by our customers. With the operational improvements now well underway, notwithstanding the challenging external environment, the business is in good shape to continue to make further progress over the long term."

Enquiries:

Xaar plc

+44 (0) 1223 423 663聽

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Tulchan Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTSFIFWFEDSEDF

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS